@Roche Roche

Roche posts on X about $rog, $rhhby, people with, approved the most. They currently have [-------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

• [--] Week [-----] -73%
• [--] Month [------] +107%
• [--] Months [---------] +457%
• [--] Year [---------] +5,899%

Mentions: [--] #

• [--] Week [--] +20%
• [--] Month [--] -40%
• [--] Months [---] +340%
• [--] Year [---] +190%

Followers: [-------] #

• [--] Week [-------] -0.01%
• [--] Month [-------] -0.09%
• [--] Months [-------] -1.10%
• [--] Year [-------] -1.90%

CreatorRank: [---------] #

Social Influence

Social category influence cryptocurrencies 67.89% finance 9.17% countries 6.42% stocks 1.83% travel destinations 0.92%

Social topic influence $rog #1, $rhhby #3, people with 5.5%, approved 4.59%, acquisition 4.59%, longterm 2.75%, we are 1.83%, investment 1.83%, malawi 1.83%, sanofi 1.83%

Top accounts mentioned or mentioned by @yachmod @mikeycolombia33 @who @nejm @businessatoecd @g7 @cdnchamberofcom @isedca @innovativemeds @admarebio @sanofi @orencsak @canadabusiness @francolombo2019 @oecdsocial @davidelviram @gcmccauley @g7canada @hansclevers @flatironhealth

Top assets mentioned ROGin AI (ROG) Sanofi (SNY)

Top Social Posts

Top posts by engagements in the last [--] hours

"MEDIA - Were pleased to share new Phase III data at #ACTRIMSForum for our investigational medicine in primary progressive multiple sclerosis. $RHHBY $ROG https://www.roche.com/media/releases https://www.roche.com/media/releases"
X Link 2026-02-08T09:55Z 238.2K followers, [----] engagements

"Do you know how mass spectrometry can be used for therapeutic drug monitoring Enter a new dimension in mass spectrometry and find out how this diagnostic technique can help critically ill patients attain target concentrations. #RocheMassSpec https://go.roche.com/xtdms https://go.roche.com/xtdms"
X Link 2025-12-18T08:00Z 238.2K followers, [----] engagements

"As the needs and expectations of people living with haemophilia A continue to evolve Roches John Pasi explores how we can build on past breakthroughs to deliver more personalised care. Read the full story 👉 #HaemophiliaA #ASH2025 #PatientCentricity #InnovationInCare https://spkl.io/6015AgLZX https://spkl.io/6015AgLZX"
X Link 2025-12-08T07:00Z 238.2K followers, [----] engagements

"#MEDIA - We are pleased our medicine for adults with active #lupusnephritis is approved in the EU providing those living with this potentially life-threatening disease with a much-needed new treatment option and potential new standard of care. $ROG $RHHBY https://spkl.io/6012A9kmi https://spkl.io/6012A9kmi"
X Link 2025-12-09T09:43Z 238.2K followers, [----] engagements

"The future of faster drug discovery may be on the horizon. #Organoids tiny simplified versions of human tissues help us test potential medicines in faster more predictive ways. A new review with @Hubrecht Institute explores how. 👏 Thank you to the scientists driving this work. Read more 👉 #DrugDiscovery #Innovation #pRED @IHB_Research @Hans Clevers https://spkl.io/6017Ai1dt https://spkl.io/6017Ai1dt"
X Link 2025-12-12T07:00Z 238.2K followers, [----] engagements

"Roche reports strong [----] results with 7% (CER) sales growth driven by strong demand for medicines and diagnostic solutions. 👉 Read the full release here: $ROG $RHHBY #FinancialResults https://spkl.io/6010AqN8r https://spkl.io/6010AqN8r"
X Link 2026-01-29T06:00Z 238.2K followers, [----] engagements

"Sequencing by expansion (SBX) is built to unlock opportunities that were once out of reach. From delivering full-length reads with unmatched speed to supporting transformative research SBX currently in development at Roche sets a new benchmark for next-generation sequencing. Watch the full video to find out more about how SBX is different from another popular sequencing technology #Genomics #HumanGenetics #RocheSBX #Innovation #NGS https://go.roche.com/xsbxs https://go.roche.com/xsbxs"
X Link 2026-02-11T19:04Z 238.2K followers, [----] engagements

"The leap to tomorrow is today 🚀 Roche's new Diagnostics Innovation Center in Penzberg Germany is now officially open. This 300M investment is a massive step for innovation designed for collaboration and digitalization to accelerate test development. Better diagnostics = better lives for patients globally: #Innovation #LEAP #Penzberg #Healthcare #Technology https://go.roche.com/leapx https://go.roche.com/leapx"
X Link 2026-02-12T09:32Z 238.2K followers, [----] engagements

"#MEDIA We are excited to share positive results from our trial in people with primary membranous nephropathy the first global phase III study in this chronic autoimmune disease. #MembranousNephropathy $ROG $RHHBY https://spkl.io/6018AQKJe https://spkl.io/6018AQKJe"
X Link 2026-02-16T08:45Z 238.2K followers, [---] engagements

"On our journey to mark #WorldCOPDDay its vital that we know how impactful #COPD is worldwide. Take a look at these three stats to understand the importance of #SpeakUpforCOPD"
X Link 2023-11-09T15:00Z 246K followers, [----] engagements

"Although #COPD is the third leading cause of death worldwide there is still an urgent need for greater recognition of the impact of COPD on individuals and society to ensure people living with this disease receive the care they need and deserve"
X Link 2023-11-13T13:00Z 246K followers, [----] engagements

"@CharlyMon7 Hi Charlie. Could you send us a Direct message to ask you some questions and attend to your case Ana on behalf of the Roche Social Media team"
X Link 2023-11-22T16:54Z 246.9K followers, [--] engagements

"#MEDIA We are pleased to announce that our immunoassay to determine the presence and quantity of the #hepatitis B e antigen in human serum and plasma has received CE approval. Learn more here 👉 $ROG $RHHBY"
X Link 2023-11-27T09:05Z 246.9K followers, [----] engagements

"@san01992367 You can also contact our local Drug Safety Centre whose details are available here: Wishing you all the very best. Ana on behalf of the Roche Social Media team"
X Link 2023-11-27T13:31Z 246.8K followers, [--] engagements

"Tune in to the first episode of the SMA My Way podcast - spotlighting Spinal Muscular Atrophy (SMA) on #DisabilityDay. Let's elevate the dialogue together. #IDPD"
X Link 2023-12-03T09:00Z 246.8K followers, [----] engagements

"@AdeoyeAdemolaA1 Hi Abel Please find my reply in your DMs. Wishing you all the very best Kriszta on behalf of the Roche Social Media team"
X Link 2023-12-27T09:31Z [--] followers, [--] engagements

"For [--] years our partnership has delivered innovative diagnostic solutions enhancing patient care globally. Excited for the future #Partnership #Diagnostics #Innovation http://spkl.io/60104fJnE http://spkl.io/60104fJnE"
X Link 2024-05-31T09:00Z 246.1K followers, [----] engagements

"#MEDIA Today at the #2024SMAConference we share 5-year data from the #FIREFISH study in children with Spinal Muscular Atrophy. Thank you to the children families and all involved who have contributed to our understanding of #SMA. @CureSMA $ROG $RHHBY http://spkl.io/60164fQ8n http://spkl.io/60164fQ8n"
X Link 2024-06-07T15:01Z 245.8K followers, [----] engagements

"#MEDIA We are pleased to announce that our four-in-one combination molecular test for #SARSCoV2 #Influenza A/B viruses and #RSV has received U.S. FDA Emergency Use Authorization. Learn more: $ROG $RHHBY http://spkl.io/60144f2Vo http://spkl.io/60144f2Vo"
X Link 2024-06-10T07:00Z 245.8K followers, [----] engagements

"The European Commission has delivered a landmark approval for our ALK inhibitor in resected ALK-positive lung cancer with the potential to address an urgent unmet need and bring an important new treatment option to many more patients. $RHHBY $ROG http://spkl.io/60174f2aW http://spkl.io/60174f2aW"
X Link 2024-06-10T09:02Z 245.8K followers, [----] engagements

"One walk countless smiles. The Roche Children's Walk starts on June 11th uniting colleagues globally to support children's education. Together we're making a difference in #Malawi #Ethiopia #Cambodia and more. Join us: #RochePhilanthropy http://spkl.io/60154fCoW http://spkl.io/60154fCoW"
X Link 2024-06-11T12:30Z 246.1K followers, [----] engagements

"#MEDIA - We are pleased to announce the launch of our highly-sensitive Kappa and Lambda multiplex test to more easily diagnose patients that may have B-cell #lymphoma. Learn more: $ROG $RHHBY http://spkl.io/60114AcbX http://spkl.io/60114AcbX"
X Link 2024-06-20T08:10Z 245.8K followers, [----] engagements

"#MEDIA We are pleased to announce the launch of two new analytical units which will deliver greater efficiency and capacity to #laboratories in CE mark countries. Learn more here: $ROG $RHHBY http://spkl.io/60104AIcu http://spkl.io/60104AIcu"
X Link 2024-06-24T13:20Z 245.8K followers, [----] engagements

"#MEDIA - We are pleased to announce that @WHO has awarded prequalification to all of our #HPV screening solutions allowing governments to expand national screening programs that help prevent #cervicalcancer. Learn more: $ROG $RHHBY http://spkl.io/6018478E6 http://spkl.io/6018478E6"
X Link 2024-06-27T07:45Z 245.8K followers, [----] engagements

"#MEDIA We are pleased to announce that the CHMP has recommended EU approval of our treatment for #ParoxysmalNocturnalHaemoglobinuria - a rare life-threatening blood condition. Learn more here: $ROG $RHHBY http://spkl.io/601947H9D http://spkl.io/601947H9D"
X Link 2024-06-28T12:06Z 245.8K followers, [----] engagements

"#MEDIA The #CHMP has issued a positive recommendation for our bispecific antibody for the treatment of macular edema due to RVO furthering our mission to save peoples sight from the leading causes of #VisionLoss. $ROG $RHHBY http://spkl.io/601647HYi http://spkl.io/601647HYi"
X Link 2024-06-28T13:00Z 245.8K followers, [----] engagements

"#MEDIA We are happy to announce that the U.S. FDA has approved the single-dose pre-filled syringe of the first and only bispecific antibody to treat three leading causes of #VisionLoss - nAMD DME and RVO. $ROG $RHHBY http://spkl.io/6017479uV http://spkl.io/6017479uV"
X Link 2024-07-05T09:18Z 245.9K followers, [----] engagements

"#MEDIA We are pleased to announce the reintroduction of our refillable eye implant in the US for the treatment of nAMD the leading cause of #VisionLoss in people over the age of [--]. $ROG $RHHBY http://spkl.io/601247tPo http://spkl.io/601247tPo"
X Link 2024-07-08T20:29Z 245.8K followers, [----] engagements

"#MEDIA Were happy to announce late-breaking data at #ASRS2024 from the long-term study of our bispecific antibody for the treatment of DME - welcome news for the millions of people at risk of #VisionLoss. $ROG $RHHBY http://spkl.io/60194CrS5 http://spkl.io/60194CrS5"
X Link 2024-07-17T16:07Z 245.9K followers, [----] engagements

"#MEDIA Were proud to present new two-year data on two serious diabetic eye conditions for our refillable eye implant at #ASRS2024. Additionally the US FDA has accepted our application for the potential approval of the implant in these conditions. $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2024-07-18 https://www.roche.com/media/releases/med-cor-2024-07-18 https://www.roche.com/media/releases/med-cor-2024-07-18 https://www.roche.com/media/releases/med-cor-2024-07-18"
X Link 2024-07-18T12:31Z 245.9K followers, [----] engagements

"We are pleased to announce today the completion of the acquisition of @LumiraDxs Point of Care diagnostics technology enabling us to expand patient access to timely diagnostics results in decentralised healthcare settings worldwide. $ROG $RHHBY ➡ http://spkl.io/60164CC6G http://spkl.io/60164CC6G"
X Link 2024-07-29T05:32Z 245.9K followers, [----] engagements

"#MEDIA Our bispecific antibody has received approval from the European Commission for the treatment of macular edema secondary to retinal vein occlusion (RVO)furthering our mission to save peoples sight from the leading causes of #VisionLoss. $ROG $RHHBY http://spkl.io/60114h8iv http://spkl.io/60114h8iv"
X Link 2024-07-30T08:45Z 245.9K followers, [----] engagements

"#MEDIA We are supporting @WHO declaration of a global health emergency due to the ongoing #mpox outbreak with diagnostic tests developed for mpox formerly known as #monkeypox. Learn more: $ROG $RHHBY http://spkl.io/6018f6pRy http://spkl.io/6018f6pRy"
X Link 2024-08-20T13:03Z 245.4K followers, [----] engagements

"#MEDIA We are pleased to announce that the European Commission has approved our treatment for paroxysmal nocturnal haemoglobinuria in the EU. Learn more: $ROG $RHHBY #PNH http://spkl.io/6012f6xoo http://spkl.io/6012f6xoo"
X Link 2024-08-27T09:30Z 245.3K followers, [----] engagements

"Roche and SAS Brasil are joining forces to provide holistic solutions and better cervical cancer outcomes for women in Brazil. Learn more #TogetherForChange #Partnerships #XProject http://spkl.io/6013fBdt3 http://spkl.io/6013fBdt3"
X Link 2024-09-04T07:00Z 245.3K followers, [----] engagements

"#MEDIA We are proud to announce the inauguration of the Roche pRED Innovation Centre in Basel. This new cutting-edge facility is ready to lead the way in medical research and innovation and deliver meaningful impact to patients. Learn more here: http://spkl.io/6015f8Hkv http://spkl.io/6015f8Hkv"
X Link 2024-09-11T05:00Z 245.3K followers, [----] engagements

"#MEDIA The FDA approved the subcutaneous injection of our #cancer immunotherapy for certain lung liver skin and soft tissue cancer types. This approval is part of our commitment to offering patients and healthcare providers more options. $RHHBY $ROG http://spkl.io/6011f8XQ1 http://spkl.io/6011f8XQ1"
X Link 2024-09-13T10:04Z 244.1K followers, [----] engagements

"#MEDIA- We are pleased to announce that our #antiviral showed a significant reduction in the transmission of #influenza from an individual with the infection to household members in a Phase III study. $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2024-09-19 https://www.roche.com/media/releases/med-cor-2024-09-19"
X Link 2024-09-19T07:02Z 244.1K followers, [----] engagements

"#MEDIA We are pleased to announce our first test to use breakthrough technology that can detect [--] respiratory viruses simultaneously on our high throughput analysers. Learn more: $ROG $RHHBY http://spkl.io/6015fJizJ http://spkl.io/6015fJizJ"
X Link 2024-09-24T08:36Z 244.1K followers, [----] engagements

"#MEDIA We are excited to announce first data from a phase III study in people with active #LupusNephritis. This study reflects our ongoing commitment to people living with kidney and kidney-related diseases. $ROG $RHHBY http://spkl.io/6015fJxp5 http://spkl.io/6015fJxp5"
X Link 2024-09-26T07:51Z 244.1K followers, [----] engagements

"How to create a lasting impact on Kenya's breast cancer care Learn more barriers through #TogetherForChange #Partnerships #XProject http://spkl.io/6015fBHi1 http://spkl.io/6015fBHi1"
X Link 2024-10-02T13:00Z 244K followers, [----] engagements

"#MEDIA - We are pleased to announce the first companion diagnostic test to receive CE Mark approval for determining CLDN18 protein expression in tumours of patients with gastric or gastroesophageal junction (GEJ) #cancer. Learn more: $ROG $RHHBY http://spkl.io/6016fPd3y http://spkl.io/6016fPd3y"
X Link 2024-10-10T07:50Z 244.2K followers, [----] engagements

"#MEDIA The FDA has approved our medicine for advanced HR-positive HER2-negative #BreastCancer with a PIK3CA mutation one of the most commonly mutated genes in HR-positive disease associated with poor prognosis. $ROG $RHHBY http://spkl.io/6013fPIsx http://spkl.io/6013fPIsx"
X Link 2024-10-11T13:01Z 244.2K followers, [----] engagements

"#MEDIA We are pleased to announce data from a first-of-its-kind phase IV study in historically underrepresented people with diabetic macular edema reflecting our commitment to diverse and inclusive research. $ROG $RHHBY http://spkl.io/6017fROF9 http://spkl.io/6017fROF9"
X Link 2024-10-18T21:18Z 244K followers, [----] engagements

"📢 Roches strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months 👉 Read the full media release here: $ROG $RHHBY #RocheFinancialResults #earnings http://spkl.io/6011fRUUD http://spkl.io/6011fRUUD"
X Link 2024-10-23T05:10Z 243.8K followers, [----] engagements

"🚀We are delighted to see three of our innovation engines on the prestigious @ScienceCareers [----] Top Employers list🔝 We would like to thank all the teams who made this achievement possible. Were more motivated than ever to tackle the challenges that lie ahead💪 Read more about it here: http://spkl.io/6042fRCSk Congratulations to Insmed @Regeneron @Incyte @VertexPharma @Syngenta @spark_tx @Alnylam @Roche @Bioconlimited and @genentech for making it to the top [--] in the Top Employers' rankings #SCTopEmployers 👉View the full article online: https://t.co/ChumK795HU https://t.co/1zvNy4wbF2"
X Link 2024-10-25T07:33Z 244.3K followers, [----] engagements

"#MEDIA - We are pleased that phase III data for our medicine for people with advanced PIK3CA-mutated HR-positive HER2-negative breast cancer have been published in the New England Journal of Medicine. Find out more on $ROG $RHHBY http://spkl.io/6016frL10 http://spkl.io/6016frL10"
X Link 2024-10-31T10:31Z 243.8K followers, [----] engagements

"#MEDIA - we are pleased to present new data at the 17th Clinical Trials in Alzheimers Disease congress (CTAD) demonstrating our growing momentum in diagnostics for Alzheimers disease. Learn more: $ROG $RHHBY #Alzheimers http://spkl.io/6011frFbN http://spkl.io/6011frFbN"
X Link 2024-10-31T13:50Z 243.8K followers, [----] engagements

"The power of partnerships can transform healthcare. Through collaboration we're paving the way in fighting breast cancer in Algeria. Learn more #TogetherForChange #Partnerships #XProject Find out more on: http://spkl.io/6012frXWn http://spkl.io/6012frXWn"
X Link 2024-11-02T07:00Z 245.1K followers, [----] engagements

"Not sure how to transform your workspace into a more diabetes-friendly environment Shelley and other Roche colleagues living with #diabetes share tips on how to be more inclusive. Find out more: #ConnectingWhatCounts #WorldDiabetesDay http://spkl.io/6011fTWU1 http://spkl.io/6011fTWU1"
X Link 2024-11-06T12:41Z 244.5K followers, [----] engagements

"At Roche we are committed to innovation developing pioneering medicines to deliver substantial patient benefits. Today we are excited to announce that we entered into a definitive agreement to acquire @PoseidaThera . This acquisition will enhance our combined expertise unlock new possibilities and pave the way for first-in-class therapies across various indications. #RocheInnovation #Celltherapy #Oncology $ROG $RHHBY Read more: https://www.roche.com/media/releases/med-cor-2024-11-26b https://www.roche.com/media/releases/med-cor-2024-11-26b"
X Link 2024-11-26T06:24Z 244.1K followers, [----] engagements

"#MEDIA We are pleased the U.S. FDA has accepted our supplementary Biologics License Application for our bispecific antibody combination offering a potential off-the-shelf treatment for an aggressive form of #lymphoma. ➡ $RHHBY $ROG http://spkl.io/6010fZzKC http://spkl.io/6010fZzKC"
X Link 2024-12-05T09:57Z 243.7K followers, [----] engagements

"#MEDIA We are pleased to present five-year follow-up data on our combination treatment at #ASH24 the first to advance the standard of care in frontline diffuse large B-cell #lymphoma in [--] years ➡ $RHHBY $ROG http://spkl.io/6012fZ4pn http://spkl.io/6012fZ4pn"
X Link 2024-12-09T10:43Z 243.7K followers, [----] engagements

"#MEDIA We are presenting new and long-term follow-up data on our fixed-duration bispecific antibodies at #ASH24 reinforcing their potential to advance outcomes for people living with advanced #lymphomas. ➡ $RHHBY $ROG http://spkl.io/6010fwJYA http://spkl.io/6010fwJYA"
X Link 2024-12-10T11:00Z 243.7K followers, [----] engagements

"#MEDIA - Roche is pleased to announce the CE Mark for the new and updated molecular cobas 6800/8800 systems [---] enhancing laboratory efficiency and testing capabilities. #ValueOfDiagnostics #RocheInnovation $ROG $RHHBY http://spkl.io/6015fwxdH http://spkl.io/6015fwxdH"
X Link 2024-12-13T06:42Z 243.7K followers, [----] engagements

"#MEDIA - We are pleased to announce the launch of our new solution to transform clinical mass spectrometry. Learn more: #massspectrometry #innovation #diagnostics #RocheMassSpec $ROG $RHHBY http://spkl.io/6015fbaHl http://spkl.io/6015fbaHl"
X Link 2024-12-18T06:14Z 244.1K followers, [--] engagements

"#MEDIA - We are pleased to announce the launch of our new solution to transform clinical mass spectrometry. Learn more: #massspectrometry #innovation #diagnostics #RocheMassSpec $ROG $RHHBY https://go.roche.com/MassSpecMediaRelease https://go.roche.com/MassSpecMediaRelease"
X Link 2024-12-18T06:29Z 243.7K followers, [----] engagements

"At Roche we are going beyond what was thought possible in diagnostics. Backed by science and led by #innovation we are pushing boundaries today to advance the #healthcare of tomorrow. In labs for patients for the world. #RocheMassSpec https://go.roche.com/MassSpecX https://go.roche.com/MassSpecX"
X Link 2024-12-21T23:00Z 244K followers, [----] engagements

"#MEDIA We are pleased to announce that our molecular tests to diagnose sexually transmitted infections at the point of care have received FDA clearance with CLIA waiver in the U.S. Learn more here: $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2025-01-22 https://www.roche.com/media/releases/med-cor-2025-01-22"
X Link 2025-01-22T06:05Z 243K followers, [----] engagements

"Roche reports strong [----] results with 7% (CER) sales growth; fourth quarter marks third straight quarter of 9% growth. 👉 Read the full release here: $ROG $RHHBY #FinancialResults https://spkl.io/6012fc0TK https://spkl.io/6012fc0TK"
X Link 2025-01-30T06:13Z 242.1K followers, 12.1K engagements

"#MEDIA Roche is pleased to share positive results showing our medicine has demonstrated a significant overall survival benefit for those living with advanced PIK3CA-mutated HR-positive HER2-negative #BreastCancer $ROG $RHHBY https://spkl.io/6015fcCYb https://spkl.io/6015fcCYb"
X Link 2025-01-30T15:59Z 242.1K followers, [----] engagements

"#MEDIA - We are pleased to announce FDA approval for first companion #diagnostic to identify metastatic breast cancer patients with ultralow #HER2 expression eligible for a targeted treatment option. Learn more: #PrecisionMedicine $ROG $RHHBY https://spkl.io/6010fY3T4 https://spkl.io/6010fY3T4"
X Link 2025-01-31T17:13Z 242.1K followers, [----] engagements

"#MEDIA We are delighted to announce that the US FDA has approved our refillable eye implant to treat a leading cause of #VisionLoss in adults with diabetes diabetic macular edema (DME). $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2025-02-04 https://www.roche.com/media/releases/med-cor-2025-02-04"
X Link 2025-02-04T16:56Z 242K followers, [----] engagements

"#MEDIA We are pleased to share full data from our Phase III study in #LupusNephritis being presented today at the @ISNWCN and published in the @NEJM. This study reflects our commitment to advancing the treatment of kidney diseases. $ROG $RHHBY https://spkl.io/6010fl9us https://spkl.io/6010fl9us"
X Link 2025-02-07T13:01Z 242.1K followers, [----] engagements

"#MEDIA We are pleased the CHMP has recommended EU approval of our off-the-shelf bispecific antibody combination offering a treatment that could be immediately available following relapse for people with an aggressive form of #lymphoma. $RHHBY $ROG https://spkl.io/6015fUb45 https://spkl.io/6015fUb45"
X Link 2025-02-28T14:43Z 242.1K followers, [----] engagements

"We are thrilled to celebrate our member company Chugai Pharmaceuticals 100th anniversary today Our alliance has brought benefits to patients worldwide. Here's to [---] more years of innovation 🎉 Learn more at: #Chugai100thAniversary #Roche https://spkl.io/6015fS1yW https://spkl.io/6015fS1yW"
X Link 2025-03-10T03:00Z 242.9K followers, [----] engagements

"#MEDIA We are pleased the EC has approved our first-of-a-kind bispecific antibody combination for an aggressive form of #lymphoma offering an off-the-shelf option for patients whose cancer returns or doesnt respond to initial treatment. $RHHBY $ROG https://spkl.io/6016fx6sp https://spkl.io/6016fx6sp"
X Link 2025-04-14T08:30Z 241.9K followers, [----] engagements

"Roche continues good momentum into [----] with a 6% (CER) sales growth in the first quarter. For more details on our performance click here ➡ $ROG $RHHBY #FinancialResults https://spkl.io/6011fI9Wt https://spkl.io/6011fI9Wt"
X Link 2025-04-24T05:11Z 240.9K followers, [----] engagements

"#MEDIA - We are pleased to share that our Phase III study results published in @NEJM show a significant reduction in #influenza transmission from infected individuals to household members. $ROG $RHHBY https://spkl.io/6011fItbB https://spkl.io/6011fItbB"
X Link 2025-04-25T07:55Z 240.9K followers, [----] engagements

"#MEDIA We are pleased the CHMP has recommended our medicine for HER2 - positive #BreastCancer can be given outside of the clinic (at home) helping to alleviate the burden of treatment on peoples lives and freeing up cancer care capacity. $ROG $RHHBY https://spkl.io/6019fLbmz https://spkl.io/6019fLbmz"
X Link 2025-04-30T07:30Z 240.9K followers, [----] engagements

"#MEDIA We are pleased to be presenting new ten-year data for our medicine in HER2-positive #BreastCancer at #ESMOBreast25 today. These data reflect our continued commitment to addressing unmet needs for people diagnosed with breast cancer. $ROG $RHHBY https://spkl.io/6013fFdUZ https://spkl.io/6013fFdUZ"
X Link 2025-05-13T06:45Z 240.9K followers, [----] engagements

"@BusinessatOECD @G7 @CdnChamberofCom @ISED_CA @innovativemeds @adMare_Bio @sanofi @KamalKheraLib @orencsak @canadabusiness @GovCanHealth @OECDglobal @FranColombo2019 @OECD_Social @DavidElviraM @GCMcCauley @G7Canada Looking forward to a crucial discussion on #HealthSecurity & #EconomicSecurity at next week's #B7 Summit . #G7"
X Link 2025-05-13T18:12Z 240.9K followers, [---] engagements

"@BusinessatOECD @G7 @CdnChamberofCom @innovativemeds @adMare_Bio @sanofi @OECD @IFPMA @DavidReddyIFPMA @orencsak @GCMcCauley @DavidElviraM @FranColombo2019 @OECD_Social @ISED_CA @canadabusiness @G7Canada Thanks @CdnChamberofCom for convening a powerful discussion at the #B7Summit. We were glad to stand alongside partners calling for prevention digital innovation and investment to reinforce economic and health resilience. #G7"
X Link 2025-05-19T18:58Z 240.9K followers, [---] engagements

"#MEDIA We are happy to announce that the US FDA has approved our refillable eye implant for its third indication diabetic retinopathy (DR) - a leading cause of #VisionLoss in adults with diabetes. $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2025-05-22 https://www.roche.com/media/releases/med-cor-2025-05-22"
X Link 2025-05-22T16:02Z 240.9K followers, [----] engagements

"#MEDIA We are pleased to announce new two-year follow-up data at #ASCO25 showing an extended survival benefit with our off-the-shelf bispecific antibody combination for people with an aggressive form of #lymphoma after initial relapse. $RHHBY $ROG https://spkl.io/6010fNuCI https://spkl.io/6010fNuCI"
X Link 2025-05-23T13:40Z 241K followers, [----] engagements

"#MEDIA We are pleased to announce a positive CHMP opinion for our medicine in advanced PIK3CA-mutated ER-positive HER2-negative #BreastCancer an aggressive subtype of breast cancer associated with a poor prognosis. $ROG $RHHBY https://spkl.io/6019fNTNv https://spkl.io/6019fNTNv"
X Link 2025-05-23T15:10Z 241K followers, [----] engagements

"#MEDIA New 96-week data shows maintained near-complete suppression of disease activity and no disability progression for up to two years in people with relapsing multiple sclerosis. #MultipleSclerosis #ClinicalTrials $ROG $RHHBY https://spkl.io/6014ffUv2 https://spkl.io/6014ffUv2"
X Link 2025-05-30T07:11Z 241K followers, [----] engagements

"#MEDIA We are pleased to be presenting new overall survival data at #ASCO25 for our medicine in people with advanced PIK3CA-mutated HR-positive HER2-negative #BreastCancer supporting standard of care potential. $ROG $RHHBY https://spkl.io/6018ffNsm https://spkl.io/6018ffNsm"
X Link 2025-05-31T12:58Z 241K followers, [----] engagements

"#MEDIA We are very encouraged about the Phase III data being presented at #ASCO25 by @Alliance_org in #coloncancer. Huge thanks to Alliance the investigators and patients taking part in this study. $ROG $RHHBY"
X Link 2025-06-01T18:15Z 241K followers, [----] engagements

"#MEDIA We are pleased our Phase III data at #ASCO25 published in #TheLancet show survival benefits for people with small cell #lungcancer. SCLC is an aggressive cancer type where more options for disease control are highly needed: $ROG $RHHBY https://spkl.io/6016fAn54 https://spkl.io/6016fAn54"
X Link 2025-06-03T08:32Z 241K followers, [----] engagements

"#MEDIA We are advancing our investigational anti-alpha-synuclein antibody into Phase III development for early-stage #ParkinsonsDisease $ROG $RHHBY https://spkl.io/6016fC0xi https://spkl.io/6016fC0xi"
X Link 2025-06-16T08:46Z 240.8K followers, [----] engagements

"Pharma and academia play distinct but complementary roles in driving innovation. In a new @Nature article @HansClevers shares insights on how bridging both worlds can accelerate progress in healthcare. Read more here: https://spkl.io/6010fhJIC https://spkl.io/6010fhJIC"
X Link 2025-06-19T22:00Z 241K followers, [----] engagements

"#MEDIA We're pleased to share new late-breaking data at #18ICML showing that our investigational combination treatment could offer people with aggressive #lymphoma a well-tolerated option without traditional chemotherapy. $RHHBY $ROG https://spkl.io/6010fh0JC https://spkl.io/6010fh0JC"
X Link 2025-06-20T16:00Z 240.9K followers, [----] engagements

"#MEDIA - Were pleased to announce we have received CE mark for our blood test to rule out Alzheimers disease. This minimally invasive test can reduce the need for additional confirmatory investigations. $RHHBY $ROG http://www.roche.com/media http://www.roche.com/media"
X Link 2025-07-23T05:30Z 240.8K followers, [----] engagements

"#MEDIA We are pleased to announce that the European Commission has approved our medicine for PIK3CA-mutated ER-positive HER2-negative advanced #BreastCancer helping to address an urgent unmet need. $ROG $RHHBY https://go.roche.com/eucom https://go.roche.com/eucom"
X Link 2025-07-23T11:00Z 240.7K followers, [----] engagements

"Roche continues strong momentum with 7% growth (CER) in the first half of [----] full-year outlook confirmed. For more details on our performance click here ➡ $ROG $RHHBY #RocheFinancialResults https://go.roche.com/xhyr https://go.roche.com/xhyr"
X Link 2025-07-24T05:06Z 240.7K followers, [----] engagements

"#MEDIA - Were pleased to share new insights in Alzheimer's disease research across our diagnostics and treatment pipelines at #AAIC25. The new data underscores Roches uniquely integrated end-to-end approach to addressing Alzheimers. $RHHBY $ROG https://www.roche.com/media https://www.roche.com/media"
X Link 2025-07-28T08:10Z 240.8K followers, [----] engagements

"#MEDIA - We are pleased to be presenting new five-year data at #ASRS2025 today. These data highlight that our refillable eye implant continues to provide long-term vision outcomes in neovascular age-related macular degeneration (nAMD) - the leading cause of vision loss in people aged over [--]. https://www.roche.com/media/releases/med-cor-2025-08-01 https://www.roche.com/media/releases/med-cor-2025-08-01"
X Link 2025-08-01T22:48Z 241K followers, [----] engagements

"#MEDIA Excited to announce that we entered into a definitive merger agreement with 89bio a key step in tackling Metabolic Dysfunction-Associated Steatohepatitis (MASH) a serious liver disease linked to obesity. This move enhances our CVRM portfolio and deepens our commitment to metabolic health. Read more: https://spkl.io/6018AR06n https://spkl.io/6018AR06n"
X Link 2025-09-18T05:03Z 240.8K followers, [----] engagements

"Sequencing breakthroughs are within reach 🚀 Roche's SBX technology is set to accelerate genomics research while maintaining top quality and performance. What do you see as the biggest advantage of faster high-quality sequencing data analysis #Genomics #Science #Biotech Faster diagnoses Accelerate drug discovery All of the above Efficient research flows Faster diagnoses Accelerate drug discovery All of the above Efficient research flows"
X Link 2025-09-19T11:11Z 240.8K followers, [----] engagements

"The answer is all of the above Faster flexible and high-quality sequencing data analysis has the potential to bring incredible benefits to the world of science and healthcare Find out more here: https://go.roche.com/xsbxdapoll https://go.roche.com/xsbxdapoll"
X Link 2025-09-26T08:07Z 240.8K followers, [---] engagements

"Honored to see @HansClevers recognized Abarca Prize in Spain A remarkable achievement that demonstrates how science and compassion go hand in hand. Find out more about #AbarcaPrize #ResearchPrize #EarlyDevelopment #MedicalResearch https://spkl.io/6013ApTSd https://spkl.io/6013ApTSd"
X Link 2025-10-01T16:27Z 240.7K followers, 15.5K engagements

"@msdrx Glad you like it - thanks for the kind feedback"
X Link 2013-02-07T16:23Z 242.3K followers, [--] engagements

"Roche employees around the world walk for children in Malawi and raise funds http://t.co/4MbR7wxixW #RoCW via @yellowdayzy - South Africa http://ow.ly/y4Tyf http://ow.ly/y4Tyf"
X Link 2014-06-16T15:05Z 245.3K followers, [--] engagements

"Don't miss #ESMO14 Presidential Session in Room Madrid 4pm CET for discussion of our new #breastcancer data: http://t.co/cLclWfo5JF http://ow.ly/C2jGE http://ow.ly/C2jGE"
X Link 2014-09-28T13:23Z 245.3K followers, [--] engagements

"Roche reports strong results in 2015: $ROG $RHHBY #pharma http://ow.ly/XCF7f http://ow.ly/XCF7f"
X Link 2016-01-28T18:31Z 245.3K followers, [--] engagements

"Roche CEO Severin Schwan summarizes [----] full-year performance. $ROG $RHHBY"
X Link 2017-02-01T20:30Z 245.3K followers, [--] engagements

"In [----] Roches Group sales rose 4% at constant exchange rates to CHF [----] bn. $ROG $RHHBY"
X Link 2017-02-01T21:15Z 245.8K followers, [--] engagements

"What life with #RheumatoidArthritis really looks like. A young artist from Slovenia shares his story. #WAAD17 http://ow.ly/p8O330bRQGd http://ow.ly/p8O330bRQGd"
X Link 2017-05-20T09:40Z 245.2K followers, [--] engagements

"#Media: #Innovation in HIV testing is increasing access to testing for patients living in remote locations. https://cards.twitter.com/cards/18ce53vuuym/5775m https://cards.twitter.com/cards/18ce53vuuym/5775m"
X Link 2018-01-06T14:35Z 241K followers, [--] engagements

"Pharma sales rose 5% at constant exchange rates to CHF [----] bn. New products drove 65% of divisional growth. $ROG $RHHBY"
X Link 2018-02-01T06:13Z 245.3K followers, [--] engagements

"In [----] both our Pharmaceuticals and Diagnostics Divisions showed good growth. $ROG $RHHBY"
X Link 2018-02-01T09:09Z 245.3K followers, [--] engagements

"Find out about our contributions to a healthier society. Take a journey through the stories behind the numbers in our annual report. $ROG $RHHBY"
X Link 2018-02-01T09:16Z 245.3K followers, [--] engagements

"Roche Group sales increased 5% at constant exchange rates to CHF [----] billion in [----]. $ROG $RHHBY"
X Link 2018-02-01T18:52Z 245.3K followers, [--] engagements

"We're proud to announce our acquisition with @flatironhealth to accelerate industry-wide development and delivery of breakthrough medicines for patients with #cancer. $ROG $RHHBY http://ow.ly/hnm730irex4 http://ow.ly/hnm730irex4"
X Link 2018-02-16T09:00Z 245.3K followers, [--] engagements

"We're proud to announce our acquisition with @flatironhealth. By coming together with Flatiron we'll leverage our combined expertise to advance the use of real-world evidence to set new industry standards for #oncology research and development. $ROG $RHHBY http://ow.ly/YDeJ30irhXh http://ow.ly/YDeJ30irhXh"
X Link 2018-02-16T11:55Z 245.3K followers, [---] engagements

"Roche receives EU approval for its treatment for #hemophilia A with inhibitors. $ROG $RHHBY http://ow.ly/y9JY30iE5kX http://ow.ly/y9JY30iE5kX"
X Link 2018-02-27T16:45Z 245.3K followers, [--] engagements

"Roche announces positive results from a Phase III cancer #immunotherapy combination study for the initial treatment of #lungcancer. $ROG $RHHBY http://ow.ly/z5Jv30j2Pwd http://ow.ly/z5Jv30j2Pwd"
X Link 2018-03-20T07:51Z 245.3K followers, [--] engagements

"We're happy to announce that as of today our acquisition with Flatiron Health is complete. $ROG $RHHBY #oncology"
X Link 2018-04-06T09:45Z 245.4K followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing